Doctors are questioning the value proposition of national, state and local medical societies. In addition, their membership base has shifted from independent physicians in private practice to employed physicians working for fewer and fewer consolidated integrated delivery networks with more and more market and employer power.
Consequently, medical professional societies are rethinking their traditional missions of advocacy, education and professional domain specific professional development.
Here are some reasons why they should offer biomedical and clinical innovation and entrepreneurship education and training:
Many offer courses in various aspects of practice management. Unfortunately, while operations management is important and cash flow mission critical, they should be teaching medical practice entrepreneurship and preaching the gospel of Othercare.
Some medical societies resist because "we don't want to teach doctors how to leave practice" when the reality is that practicing entrepreneurship as a doctor, i.e. the pursuit of opportunity with scarce resources and conditions of uncertainty with the goal of creating user defined value through the deployment of innovation, is not an either/or proposition.
Medical societies should offer their members bioentrepreneurship education and training because it's what their members want, it adds value to their practice and their employers, it's good for patients and it helps the societies retain members. What's there not to like?
Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs.
Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.